DS Strayer, E Herting, B Sun and B Robertson
Department of Pathology and Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.

It has been suggested that surfactant protein-A (SP-A) protects surfactant activity from inhibitors such as fibrinogen. Substantial evidence indicates that inhibition of surfactant activity is often important in the pathogenesis of acute respiratory failure. Studies on surfactant function in the pulsating bubble surfactometer imply that SP- A helps to maintain low surface tension in the presence of inhibitors such as fibrinogen. We tested whether SP-A acts in this way in vivo. Rabbit pups, 29 d gestational age, were treated with a monoclonal antibody to rabbit SP-A (R5) followed by fibrinogen, or with control preparations (normal IgG and saline, respectively). Lung compliance was measured during ventilation throughout these experiments. Air-space volume and pulmonary edema were quantitated morphometrically. Animals receiving anti-SP-A antibody + fibrinogen showed substantial and significant impairment in lung compliance compared with control littermates receiving normal IgG and/or saline. Lungs from these animals showed decreased pulmonary air-space volume and increased alveolar edema. We conclude that SP-A protects pulmonary surfactant from inhibition by fibrinogen in vivo. This protective activity may be important in the pathogenesis of both adult and neonatal respiratory distress syndromes, and it may also be useful in devising therapies for these diseases.

This article has been cited by other articles:

				T. C. Bailey, A. A. Maruscak, A. Petersen, S. White, J. F. Lewis, and R. A. W. Veldhuizen Physiological effects of oxidized exogenous surfactant in vivo: effects of high tidal volume and surfactant protein A Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L703 - L709. [Abstract] [Full Text] [PDF]

				T. W. Wright, R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti Pulmonary Inflammation Disrupts Surfactant Function during Pneumocystis carinii Pneumonia Infect. Immun., February 1, 2001; 69(2): 758 - 764. [Abstract] [Full Text] [PDF]

				M. OCHS, I. NENADIC, A. FEHRENBACH, J. M. ALBES, T. WAHLERS, J. RICHTER, and H. FEHRENBACH Ultrastructural Alterations in Intraalveolar Surfactant Subtypes after Experimental Ischemia and Reperfusion Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 718 - 724. [Abstract] [Full Text]

				C. CASALS, A. VARELA, M. L. F. RUANO, F. VALIÑO, J. PÉREZ-GIL, N. TORRE, E. JORGE, F. TENDILLO, and J. L. CASTILLO-OLIVARES Increase of C-Reactive Protein and Decrease of Surfactant Protein A in Surfactant after Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 43 - 49. [Abstract] [Full Text]

				E. Herting, B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 3F - 8. [Abstract] [Full Text]